"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Divis Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs	Chairman : Ramesh B V Nimmagadda
Home : Indian Private	Book Value: 561.0868795
BSE Code : 532488	Market Cap: 176604.3
NSE Code : DIVISLAB	P / E : 79.98

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	2536.00	2297.00	2302.00	2063.00
Other Income	87.00	82.00	105.00	79.00
Total Income	2623.00	2379.00	2407.00	2142.00
Total Expenditure	1655.00	1550.00	1573.00	1442.00
Operating Profit	968.00	829.00	834.00	700.00
Interest	0.00	0.00	1.00	0.00
Gross Profit	968.00	829.00	833.00	700.00
Depreciation	107.00	99.00	98.00	97.00
Tax	225.00	172.00	218.00	178.00
Deferred Tax	-31.00	-36.00	-1.00	-5.00
Reported Profit After Tax	667.00	594.00	518.00	430.00

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView